Regentis Biomaterials RGNT
NYSE RGNT
$2.10 +0.04 (+1.94%)
At close: Aug 21, 2026 · 4:00 PM EDT

Regentis Biomaterials (RGNT) Invested Capital (2024 - 2025)

Regentis Biomaterials (RGNT) posted quarterly Invested Capital of $1.2 million for Q4 2025, up 108.9% year-over-year from $573000.0 in Q4 2024, and up 108.9% quarter-over-quarter from $573000.0 in Q4 2024.

Regentis Biomaterials (RGNT) Invested Capital (2024 - 2025) Analysis & Trends

Regentis Biomaterials (RGNT) has reported Invested Capital for 2 consecutive years, with $1.2 million the latest figure, recorded in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn -
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn 3.30 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn 4.72 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 259.95 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn 29.00 Mn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn -
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn 209.00 Mn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn 598.90 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn 844.00 Mn
10 Regentis Biomaterials 1.21 Mn -6.17 Mn - 1.20 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.20 Mn
Dec 31, 2024 573,000.00